Loading organizations...
Loading organizations...
Transformative disease modification for neurological conditions.
Neumirna Therapeutics has raised $23.3M across 1 funding round.
Neumirna Therapeutics has raised $23.3M in total across 1 funding round.
Neumirna Therapeutics has raised $23.3M in total across 1 funding round.
Neumirna Therapeutics's investors include Invivo Capital.
Neumirna Therapeutics has raised $23.3M across 1 funding round. Most recently, it raised $23.3M Series A in January 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 8, 2025 | $23.3M Series A | Invivo Capital |